Recent News

• 03.11.2025 - ​Legend Biotech Reports Fourth Quarter 2024 Financial Results
• 03.11.2025 - ​Legend Biotech Reports Fourth Quarter 2024 Financial Results
• 03.11.2025 - Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights
• 03.11.2025 - Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights
• 02.25.2025 - Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results
• 02.25.2025 - Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results
• 01.14.2025 - 43rd Annual JP Morgan Healthcare Conference
• 01.14.2025 - 43rd Annual JP Morgan Healthcare Conference

Recent Filings

• 03.11.2025 - EX-99.1 EX-99.1
• 03.11.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.11.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.22.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.14.2025 - EX-99.1 EX-99.1
• 01.14.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.10.2025 - 144 Report of proposed sale of securities
• 12.26.2024 - 144 Report of proposed sale of securities